Search research articles
Contact Us
Filters
Showing results (1-10 of 51) with videos related to
Page
of 6
Sort By:
Cardiovascular Drugs and Therapy
|
June 18, 1999
Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
C Smith, M Teitler
British Journal of Pharmacology
|
January 5, 2011
Antagonist interaction with the human 5-HT(7) receptor mediates the rapid and potent inhibition of non-G-protein-stimulated adenylate cyclase activity: a novel GPCR effect
M T Klein, M Teitler
British Journal of Pharmacology
|
January 21, 2012
Distribution of 5-ht(1E) receptors in the mammalian brain and cerebral vasculature: an immunohistochemical and pharmacological study
M T Klein, M Teitler
Synapse (New York, N.Y.)
|
June 1, 1993
Quantitative autoradiographic analysis of [3H]carfentanil binding to mu opiate receptors in the rat brain
L W Fitzgerald, M Teitler
Critical Reviews in Neurobiology
|
January 1, 1994
Multiple serotonin receptor subtypes: molecular cloning and functional expression
M Teitler, K Herrick-Davis
Neuroscience Letters
|
March 2, 1992
Quantitative autoradiography of 5-CT-sensitive (5-HT1D) and 5-CT-insensitive (5-HT1E) serotonin receptors in human brain
K J Miller, M Teitler
The Journal of Pharmacology and Experimental Therapeutics
|
September 19, 2000
Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors
K Herrick-Davis, E Grinde, M Teitler
Annals of the New York Academy of Sciences
|
February 3, 1999
Creation of a constitutively activated state of the 5-HT2A receptor by site-directed mutagenesis: revelation of inverse agonist activity of antagonists
C Egan, K Herrick-Davis, M Teitler
Journal of Neurochemistry
|
September 1, 1997
Activating mutations of the serotonin 5-HT2C receptor
K Herrick-Davis, C Egan, M Teitler
The Journal of Pharmacology and Experimental Therapeutics
|
July 10, 1998
Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs
C T Egan, K Herrick-Davis, M Teitler
Page
of 6
Search research articles
Search
Showing results (1-10 of 51) with videos related to
Sort By:
Page
of 6
Cardiovascular Drugs and Therapy
|
June 18, 1999
Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors
C Smith, M Teitler
British Journal of Pharmacology
|
January 5, 2011
Antagonist interaction with the human 5-HT(7) receptor mediates the rapid and potent inhibition of non-G-protein-stimulated adenylate cyclase activity: a novel GPCR effect
M T Klein, M Teitler
British Journal of Pharmacology
|
January 21, 2012
Distribution of 5-ht(1E) receptors in the mammalian brain and cerebral vasculature: an immunohistochemical and pharmacological study
M T Klein, M Teitler
Synapse (New York, N.Y.)
|
June 1, 1993
Quantitative autoradiographic analysis of [3H]carfentanil binding to mu opiate receptors in the rat brain
L W Fitzgerald, M Teitler
Critical Reviews in Neurobiology
|
January 1, 1994
Multiple serotonin receptor subtypes: molecular cloning and functional expression
M Teitler, K Herrick-Davis
Neuroscience Letters
|
March 2, 1992
Quantitative autoradiography of 5-CT-sensitive (5-HT1D) and 5-CT-insensitive (5-HT1E) serotonin receptors in human brain
K J Miller, M Teitler
The Journal of Pharmacology and Experimental Therapeutics
|
September 19, 2000
Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors
K Herrick-Davis, E Grinde, M Teitler
Annals of the New York Academy of Sciences
|
February 3, 1999
Creation of a constitutively activated state of the 5-HT2A receptor by site-directed mutagenesis: revelation of inverse agonist activity of antagonists
C Egan, K Herrick-Davis, M Teitler
Journal of Neurochemistry
|
September 1, 1997
Activating mutations of the serotonin 5-HT2C receptor
K Herrick-Davis, C Egan, M Teitler
The Journal of Pharmacology and Experimental Therapeutics
|
July 10, 1998
Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs
C T Egan, K Herrick-Davis, M Teitler
Page
of 6